Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06550518
Status:
COMPLETED
Last Update Posted:
None
First Post:
2021-06-18
Brief Title:
Real-life Second-line Epirubicin-Paclitaxel Regimen as Treatment of Relapsed Small-Cell Lung Cancer EpiTax Study
Sponsor:
None
Organization:
None
Conditions & Keywords Data
Conditions:
Keywords: